IL161866A0 - Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives - Google Patents

Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Info

Publication number
IL161866A0
IL161866A0 IL16186602A IL16186602A IL161866A0 IL 161866 A0 IL161866 A0 IL 161866A0 IL 16186602 A IL16186602 A IL 16186602A IL 16186602 A IL16186602 A IL 16186602A IL 161866 A0 IL161866 A0 IL 161866A0
Authority
IL
Israel
Prior art keywords
tetrahydrofuran derivatives
substituted tetracyclic
mandelate salts
tetracyclic tetrahydrofuran
novel
Prior art date
Application number
IL16186602A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL161866A0 publication Critical patent/IL161866A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
IL16186602A 2001-11-09 2002-11-08 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives IL161866A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204465 2001-11-09
PCT/EP2002/011136 WO2003040122A1 (en) 2001-11-09 2002-11-08 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Publications (1)

Publication Number Publication Date
IL161866A0 true IL161866A0 (en) 2005-11-20

Family

ID=8181272

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16186602A IL161866A0 (en) 2001-11-09 2002-11-08 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
IL161866A IL161866A (en) 2001-11-09 2004-05-06 Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161866A IL161866A (en) 2001-11-09 2004-05-06 Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Country Status (25)

Country Link
US (1) US7317115B2 (no)
EP (1) EP1446397B1 (no)
JP (1) JP2005508988A (no)
KR (1) KR100962325B1 (no)
CN (1) CN1582282B (no)
AR (1) AR037285A1 (no)
AT (1) ATE299138T1 (no)
AU (1) AU2002349327B2 (no)
BR (1) BR0212770A (no)
CA (1) CA2465043C (no)
DE (1) DE60204982T2 (no)
EA (1) EA006980B1 (no)
ES (1) ES2244818T3 (no)
HR (1) HRP20040395A2 (no)
HU (1) HUP0402224A3 (no)
IL (2) IL161866A0 (no)
MX (1) MXPA04004365A (no)
MY (1) MY128237A (no)
NO (1) NO328548B1 (no)
NZ (1) NZ531739A (no)
PL (1) PL368456A1 (no)
TW (1) TW200407117A (no)
UA (1) UA79248C2 (no)
WO (1) WO2003040122A1 (no)
ZA (1) ZA200403454B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60203937T2 (de) * 2001-12-07 2006-05-11 Janssen Pharmaceutica N.V. Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
RU2401257C2 (ru) 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
MX2007009092A (es) 2005-01-27 2007-09-12 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos heterociclicos como inhibidores de 5ht2 en el tratamiento de trastornos del sistema nervioso central.
AU2006259020C1 (en) 2005-06-17 2012-01-19 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
US8765223B2 (en) * 2008-05-08 2014-07-01 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8507040B2 (en) 2008-05-08 2013-08-13 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8962675B1 (en) * 2013-09-12 2015-02-24 Abbvie Inc. Atrasentan mandelate salts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3644462A1 (de) * 1986-12-24 1988-07-07 Basf Ag Verfahren zur herstellung von 5h-dibenzo(a,d)cyclohepten-5-onen
JP2656720B2 (ja) * 1992-12-09 1997-09-24 武田薬品工業株式会社 光学活性アミノクマラン誘導体
ATE201680T1 (de) * 1994-03-16 2001-06-15 Cenes Ltd 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
DE69720709T2 (de) * 1996-04-12 2004-03-11 Janssen Pharmaceutica N.V. Substituierte tetracyclische tetrahydrofuranderivate
KR19990044257A (ko) 1996-05-20 1999-06-25 디르크 반테 생체이용율이 개선된 항진균성 조성물
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US6281247B1 (en) * 1998-03-03 2001-08-28 Novo Nordisk A/S Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
HUP9904624A2 (hu) * 1999-12-17 2002-01-28 Sanofi-Synthelabo Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
EP1186303A3 (en) * 2000-09-06 2003-12-10 Pfizer Products Inc. Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist

Also Published As

Publication number Publication date
ZA200403454B (en) 2005-08-31
CN1582282A (zh) 2005-02-16
NO20041848L (no) 2004-05-05
DE60204982D1 (de) 2005-08-11
EP1446397A1 (en) 2004-08-18
ATE299138T1 (de) 2005-07-15
ES2244818T3 (es) 2005-12-16
NO328548B1 (no) 2010-03-15
HRP20040395A2 (en) 2005-04-30
UA79248C2 (en) 2007-06-11
AR037285A1 (es) 2004-11-03
EA006980B1 (ru) 2006-06-30
EP1446397B1 (en) 2005-07-06
IL161866A (en) 2010-04-29
US7317115B2 (en) 2008-01-08
MY128237A (en) 2007-01-31
PL368456A1 (en) 2005-03-21
AU2002349327B2 (en) 2008-10-23
KR100962325B1 (ko) 2010-06-11
MXPA04004365A (es) 2004-08-11
HUP0402224A2 (hu) 2005-02-28
HUP0402224A3 (en) 2007-05-29
TW200407117A (en) 2004-05-16
US20050085533A1 (en) 2005-04-21
KR20050044310A (ko) 2005-05-12
CA2465043C (en) 2011-02-15
JP2005508988A (ja) 2005-04-07
WO2003040122A1 (en) 2003-05-15
CA2465043A1 (en) 2003-05-15
EA200400656A1 (ru) 2004-10-28
CN1582282B (zh) 2012-06-06
NZ531739A (en) 2005-02-25
DE60204982T2 (de) 2006-04-27
BR0212770A (pt) 2004-10-13

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
AP2005003343A0 (en) Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
PT1749818E (pt) Derivados de fenil-piperidina como inibidores da reabsorção da serotonina
GB0116505D0 (en) Electrosynthesis of organic compounds
IL157546A0 (en) Compounds useful as intermediates for 4-aminoquinoline derivatives
EP1485335A4 (en) PRODUCTION OF ALKYL AROMATIC COMPOUNDS
HUP0401296A3 (en) Novel processes for producing pyrimidinon derivatives
EP1415974A4 (en) PROCESS FOR THE PREPARATION OF FLUOROUS NORBORENE DERIVATIVES
IL163923A0 (en) Benzofuran derivatives
IL157889A0 (en) Substituted benzofuran-2-carboxamide derivatives
HUP0402224A3 (en) Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
IL174187A0 (en) Carbamoyl-type benzofuran derivatives
IL166592A0 (en) Novel crystalline forms of gatifloxacin
IL165115A0 (en) Novel crystalline forms of gatifloxacin
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2003214609A8 (en) Derivatives of isoflavones
AU2003297743A1 (en) Method of making tricyclic aminocyanopyridine compounds
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
SG108831A1 (en) Process for preventing formation of scale
IL165690A0 (en) Novel crystalline forms of gatifloxacin
EP1539772A4 (en) PROCESS FOR PREPARING PHOSPHORDIAMIDITE COMPOUNDS
AU2003283253A8 (en) Production of 2-kga
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
PL374044A1 (en) Methods for the preparation of mirtazapine intermediates
AU2002348365A1 (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors